• FOXO4‑DRI - NuroCore
1 1

NuroCore

FOXO4‑DRI

FOXO4‑DRI

1,250.00 AED
1,250.00 AED
Sale Sold out
Shipping calculated at checkout.
Size

FOXO4-DRI is a synthetic peptide inhibitor designed to disrupt the interaction between FOXO4 and p53, selectively driving senescent cells into apoptosis. This positions it as a cutting-edge compound in senolytic and longevity research. Within the NuroCore framework, FOXO4-DRI belongs to Cellular Regeneration & Anti-Aging Research.

View full details


Concentration: Commonly 5 mg or 10 mg vials (lyophilized powder)

Composition: Synthetic D-retro inverso peptide sequence targeting FOXO4-p53 binding

Formulation: Lyophilized acetate salt

Half-Life: Limited stability in plasma; extended biological effects via senescent cell clearance

Primary Actions: Senolytic peptide, selective apoptosis of senescent cells, longevity research


Demonstrated to clear senescent cells in experimental aging models.

Studied for extending healthspan and improving tissue regeneration.

Shown to enhance stem cell function and cellular resilience.

Explored in anti-aging, regenerative medicine, and oncology research.


Reconstitute with bacteriostatic water (NuroCore UAE standard).

Add diluent gently; swirl until fully dissolved.

Prepared solution should be handled under sterile research conditions.


Unreconstituted: Store at –20 °C; stable up to 24 months.

Reconstituted: Refrigerate at 2–8 °C; stable for 7–10 days.

Appearance: Clear, colorless solution; discard if cloudy or particulate.


Category: Cellular Regeneration & Anti-Aging Research (NuroCore UAE)

Use Case: Research into senolytics, longevity, and tissue regeneration

Compliance Note: Classified strictly as a research compound; not approved for clinical or therapeutic use

Other customers also bought

View all